The mortality from malignant neoplasms in Canada shows a steady increase from 2024 to 2028, with figures rising from 83.83 thousand to 86.41 thousand deaths. Comparing the forecasts for 2024 with the available data for 2023, a noticeable upward trend is evident, characterized by a consistent year-on-year increase averaging around 1%. The compound annual growth rate (CAGR) over this five-year period is projected to follow this pattern closely, indicating a persistent rise in mortality rates due to malignant neoplasms.
Future trends to watch for include advancements in medical treatments and detection technology, changes in lifestyle and environmental factors, and healthcare policy adaptations that aim to address the burden of malignant neoplasms. Monitoring these factors could provide insights into mitigating this upward trend in mortality.
